Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominick J Angiolillo

Showing results (121-130 of 760) with videos related to

Pageof 76
Sort By:
Giornale Italiano Di Cardiologia (2006)|February 11, 2012
[The GRAVITAS study]Fabiana Rollini, Dominick J Angiolillo, Marco Cattaneo
Journal of the American College of Cardiology|February 7, 2025
Incorporating the Totality of Ischemic and Hemorrhagic Events: The Case of the AUGUSTUS TrialBehnood Bikdeli, Dominick J Angiolillo, Marco Valgimigli
Journal of Cardiovascular Pharmacology|February 17, 2025
Deciphering the Role of In-hospital Bleeding in Acute Coronary SyndromesFelice Gragnano, Paolo Calabrò, Dominick J Angiolillo
Current Opinion in Cardiology|August 22, 2014
Perspectives on the management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and noncardiac surgeryFrancesco Franchi, Fabiana Rollini, Dominick J Angiolillo
Thrombosis and Haemostasis|March 24, 2017
Oral trans-mucosal administration of ticagrelor: is this really the future?Fabiana Rollini, Francesco Franchi, Dominick J Angiolillo
Circulation. Cardiovascular Interventions|June 10, 2015
Defining the link between chronic kidney disease, high platelet reactivity, and clinical outcomes in clopidogrel-treated patients undergoing percutaneous coronary interventionFrancesco Franchi, Fabiana Rollini, Dominick J Angiolillo
JACC. Cardiovascular Interventions|January 21, 2017
Drug-Drug Interactions When Switching Between Intravenous and Oral P2Y<sub>12</sub> Receptor Inhibitors: How Real Is It?Fabiana Rollini, Francesco Franchi, Dominick J Angiolillo
Interventional Cardiology Clinics|August 26, 2019
Pharmacodynamics During Transition Between Platelet P2Y<sub>12</sub> Inhibiting TherapiesPiera Capranzano, Bruno Francaviglia, Dominick J Angiolillo
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|June 10, 2004
Isolated distal coronary dissection in Marfan syndromeDominick J Angiolillo, Raul Moreno, Carlos Macaya
Expert Review of Cardiovascular Therapy|July 15, 2020
An updated drug profile of ticagrelor with considerations on the treatment of patients with coronary artery disease and diabetes mellitusDario Calderone, Davide Capodanno, Dominick J Angiolillo
Pageof 76

Showing results (121-130 of 760) with videos related to

Sort By:
Pageof 76
Giornale Italiano Di Cardiologia (2006)|February 11, 2012
[The GRAVITAS study]Fabiana Rollini, Dominick J Angiolillo, Marco Cattaneo
Journal of the American College of Cardiology|February 7, 2025
Incorporating the Totality of Ischemic and Hemorrhagic Events: The Case of the AUGUSTUS TrialBehnood Bikdeli, Dominick J Angiolillo, Marco Valgimigli
Journal of Cardiovascular Pharmacology|February 17, 2025
Deciphering the Role of In-hospital Bleeding in Acute Coronary SyndromesFelice Gragnano, Paolo Calabrò, Dominick J Angiolillo
Current Opinion in Cardiology|August 22, 2014
Perspectives on the management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and noncardiac surgeryFrancesco Franchi, Fabiana Rollini, Dominick J Angiolillo
Thrombosis and Haemostasis|March 24, 2017
Oral trans-mucosal administration of ticagrelor: is this really the future?Fabiana Rollini, Francesco Franchi, Dominick J Angiolillo
Circulation. Cardiovascular Interventions|June 10, 2015
Defining the link between chronic kidney disease, high platelet reactivity, and clinical outcomes in clopidogrel-treated patients undergoing percutaneous coronary interventionFrancesco Franchi, Fabiana Rollini, Dominick J Angiolillo
JACC. Cardiovascular Interventions|January 21, 2017
Drug-Drug Interactions When Switching Between Intravenous and Oral P2Y<sub>12</sub> Receptor Inhibitors: How Real Is It?Fabiana Rollini, Francesco Franchi, Dominick J Angiolillo
Interventional Cardiology Clinics|August 26, 2019
Pharmacodynamics During Transition Between Platelet P2Y<sub>12</sub> Inhibiting TherapiesPiera Capranzano, Bruno Francaviglia, Dominick J Angiolillo
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|June 10, 2004
Isolated distal coronary dissection in Marfan syndromeDominick J Angiolillo, Raul Moreno, Carlos Macaya
Expert Review of Cardiovascular Therapy|July 15, 2020
An updated drug profile of ticagrelor with considerations on the treatment of patients with coronary artery disease and diabetes mellitusDario Calderone, Davide Capodanno, Dominick J Angiolillo
Pageof 76